Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome
NCT04153201
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Antiphospholipid Syndrome
Interventions
DRUG:
Hydroxychloroquine
Sponsor
National and Kapodistrian University of Athens